Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study

Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study

Little information is available from real-life studies evaluating the efficacy of guselkumab in moderate-to-severe psoriasis. In this real-life study, we retrospectively examined a database of 52 patients with moderate-to-severe psoriasis treated with guselkumab (100 mg, s.c.) and followed for 1 yea...

Full description

Bibliographic Details
Main Authors: Marco Galluzzo, Lorenzo Tofani, Paolo Lombardo, Alessandra Petruzzellis, Dionisio Silvaggio, Colin Gerard Egan, Luca Bianchi, Marina Talamonti
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
Psoriasis
biological drugs
guselkumab
Psoriasis Area and Severity Index (PASI)
real-life
Online Access:https://www.mdpi.com/2077-0383/9/7/2170

Internet

https://www.mdpi.com/2077-0383/9/7/2170

Similar Items